Basic research

Change of transcription factor EB activity and autophagy in hippocampus of type 2 diabetic encephalopathy mice

  • Yixin CHEN ,
  • Lizhen CHENG ,
  • Yijia LIN ,
  • Ya MIAO
Expand
  • Department of Geriatrics, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China
MIAO Ya, E-mail: nning-my@163.com.

Received date: 2022-10-14

  Accepted date: 2023-02-09

  Online published: 2023-02-28

Supported by

Basic Scientific Research Fund of Shanghai Sixth People's Hospital(ynms202207)

Abstract

Objective ·To investigate the changes of transcription factor EB (TFEB), the activity of the upstream proteins and autophagy in the hippocampus of mice with type 2 diabetic encephalopathy. Methods ·Twenty healthy 8-week-old male C57BL/6J mice were randomly divided into type 2 diabetes mellitus (T2DM) group and control (CON) group, with 10 mice in each group. The T2DM group was fed with high fat feed and injected with streptozotocin (STZ); the CON group was fed with ordinary diet and injected with equal-volume sodium citrate buffer. The random blood glucose level and the body weight were measured on the mice in both groups weekly. In the 10th week, the Morris water maze behavioral experiments were performed. Then, the intraperitoneal glucose tolerance test (IPGTT) was carried out. The blood and hippocampus samples were collected after the mice were sacrificed. The plasma insulin content was detected by the ELISA kit. The protein levels of amyloid precursor protein (APP), tau protein, phospho-tau (p-tau) protein, autophagy-lysosome-related proteins [including lysosomal-associated membrane protein 1 (LAMP1), microtubule-related protein 1A/1B-light chain 3 (LC3), and P62], TFEB, p-TFEB, mammalian target of rapamycin (mTOR), p-mTOR, and mucolipin TRP cation channel 1 (MCOLN1) in the hippocampus were detected by Western blotting. The deposition of β-peptide (Aβ) and p-tau proteins in the hippocampus was detected by immunofluorescence staining. Results ·Compared with the CON group, the body weight, the random blood glucose level, the plasma insulin level, and the IPGTT results were significantly increased in the T2DM group (P<0.05). In the water maze experiments, the escape latency of the T2DM group in the place navigation increased, and the time spent in the target quadrant and the number of times crossing the platform in the spatial probe decreased (P<0.05), indicating that the ability of learning and memory of mice was damaged in the T2DM group. The levels of Aβ, APP, tau, p-tau, P62, p-TFEB, mTOR and p-mTOR proteins, and the ratios of p-tau/tau and p-mTOR/mTOR significantly increased, while the expression of LAMP1, TFEB and MCOLN1 and the ratio of LC3-Ⅱ/LC3-Ⅰ prominently decreased in the hippocampus of mice in the T2DM group in comparison with the CON group (P<0.05). Conclusion ·Alzheimer's disease-like neuropathy is observed in the hippocampus of diabetic encephalopathy mice, along with decreased TFEB activity, down-regulated autophagy function, decreased expression of MCOLN1, and enhanced mTOR activity in the hippocampus.

Cite this article

Yixin CHEN , Lizhen CHENG , Yijia LIN , Ya MIAO . Change of transcription factor EB activity and autophagy in hippocampus of type 2 diabetic encephalopathy mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(2) : 162 -170 . DOI: 10.3969/j.issn.1674-8115.2023.02.004

References

1 BIESSELS G J, DESPA F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications[J]. Nat Rev Endocrinol, 2018, 14(10): 591-604.
2 ZILLIOX L A, CHADRASEKARAN K, KWAN J Y, et al. Diabetes and cognitive impairment[J]. Curr Diab Rep, 2016, 16(9): 87.
3 BIESSELS G J, STAEKENBORG S, BRUNNER E, et al. Risk of dementia in diabetes mellitus: a systematic review[J]. Lancet Neurol, 2006, 5(1): 64-74.
4 LI Y Z, ZHANG Y Y, WANG L, et al. Autophagy impairment mediated by S-nitrosation of ATG4B leads to neurotoxicity in response to hyperglycemia[J]. Autophagy, 2017, 13(7): 1145-1160.
5 MA L Y, LV Y L, HUO K, et al. Autophagy-lysosome dysfunction is involved in Aβ deposition in STZ-induced diabetic rats[J]. Behav Brain Res, 2017, 320: 484-493.
6 WU Y Q, YE L B, YUAN Y, et al. Autophagy activation is associated with neuroprotection in diabetes-associated cognitive decline[J]. Aging Dis, 2019, 10(6): 1233-1245.
7 LIU X, ZHENG X C, LU Y L, et al. TFEB dependent autophagy-lysosomal pathway: an emerging pharmacological target in sepsis[J]. Front Pharmacol, 2021, 12: 794298.
8 PUERTOLLANO R, FERGUSON S M, BRUGAROLAS J, et al. The complex relationship between TFEB transcription factor phosphorylation and subcellular localization[J]. EMBO J, 2018, 37(11): e98804.
9 SONG W C, ZHANG C L, GOU L S, et al. Endothelial TFEB (transcription factor EB) restrains IKK (IκB kinase)-p65 pathway to attenuate vascular inflammation in diabetic db/db mice[J]. Arterioscler Thromb Vasc Biol, 2019, 39(4): 719-730.
10 YANG C, CHEN X C, LI Z H, et al. SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy[J]. Autophagy, 2021, 17(9): 2325-2344.
11 NAPOLITANO G, ESPOSITO A, CHOI H, et al. mTOR-dependent phosphorylation controls TFEB nuclear export[J]. Nat Commun, 2018, 9(1): 3312.
12 MARTINA J A, CHEN Y, GUCEK M, et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB[J]. Autophagy, 2012, 8(6): 903-914.
13 XU H X, REN D J. Lysosomal physiology[J]. Annu Rev Physiol, 2015, 77: 57-80.
14 MEDINA D L, DI PAOLA S, PELUSO I, et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB[J]. Nat Cell Biol, 2015, 17(3): 288-299.
15 SU H B, WANG X J. Proteasome malfunction activates the PPP3/calcineurin-TFEB-SQSTM1/p62 pathway to induce macroautophagy in the heart[J]. Autophagy, 2020, 16(11): 2114-2116.
16 WINZELL M S, AHRéN B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes[J]. Diabetes, 2004, 53(Suppl 3): S215-S219.
17 LUO Z X, WAN Q, HAN Y M, et al. CAPE-pNO2 ameliorates diabetic brain injury through modulating Alzheimer's disease key proteins, oxidation, inflammation and autophagy via a Nrf2-dependent pathway[J]. Life Sci, 2021, 287: 119929.
18 DENVER P, ENGLISH A, MCCLEAN P L. Inflammation, insulin signaling and cognitive function in aged APP/PS1 mice[J]. Brain Behav Immun, 2018, 70: 423-434.
19 SUN J, XU J X, LING Y, et al. Fecal microbiota transplantation alleviated Alzheimer's disease-like pathogenesis in APP/PS1 transgenic mice[J]. Transl Psychiatry, 2019, 9(1): 189.
20 SETTEMBRE C, DI MALTA C, POLITO V A, et al. TFEB links autophagy to lysosomal biogenesis[J]. Science, 2011, 332(6036): 1429-1433.
21 ZHANG X L, CHENG X P, YU L, et al. MCOLN1 is a ROS sensor in lysosomes that regulates autophagy[J]. Nat Commun, 2016, 7: 12109.
22 KIM H K, LEE G H, BHATTARAI K R, et al. TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lysosomal calcium[J]. Autophagy, 2021, 17(3): 761-778.
23 SETTEMBRE C, ZONCU R, MEDINA D L, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB[J]. EMBO J, 2012, 31(5): 1095-1108.
24 CHEN X H, GAO F, LIN C C, et al. mTOR-mediated autophagy in the hippocampus is involved in perioperative neurocognitive disorders in diabetic rats[J]. CNS Neurosci Ther, 2022, 28(4): 540-553.
Outlines

/